Tapewire

Nasdaq · USD

IRMD

IRADIMED CORP

Export transactions ↓
Tapewire entity
4896
SEC CIK
0001325618
Parsed reports
427

Last 12 months

Inside the activity.

0 purchase rows · 116 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025020
Dec 2025015
Jan 2026012
Feb 202601
Mar 2026015
Apr 2026023
May 2026022
Jun 202606
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 24, 2020 Filed Feb 26, 2020 02:21 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionCommon Stock 10,000 $0.93 $9,300.00
Disclosure

SEC source: 0000898432-20-000125 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,940

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
February 20, 2020 Filed Feb 24, 2020 17:06 UTC
Nardi Steven M.VP Manufacturing
SaleCommon Stock 1,715 $26.19 $44,915.85
Disclosure

SEC source: 0000898432-20-000124 · form4.xml · nonDerivative · entry 1

Nardi Steven M. · CIK 0001613663 · VP Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: This transaction was executed in multiple trades at prices ranging from $26.18 to $26.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 19, 2020 Filed Feb 20, 2020 21:04 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,864 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0000898432-20-000118 · form4.xml · derivative · entry 6

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 2,864 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.

F3 · derivative.expiration_date: This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
February 19, 2020 Filed Feb 20, 2020 21:04 UTC SaleCommon Stock 2,864 $26.00 $74,464.00
Disclosure

SEC source: 0000898432-20-000118 · form4.xml · nonDerivative · entry 4

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,283

F2 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 19, 2020 Filed Feb 20, 2020 21:04 UTC Exercise / conversionCommon Stock 2,864 $7.10 $20,334.40
Disclosure

SEC source: 0000898432-20-000118 · form4.xml · nonDerivative · entry 3

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,147

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 19, 2020 Filed Feb 20, 2020 21:06 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 7,453 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000119 · form4.xml · derivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,909

Underlying: Common Stock · 7,453 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
February 19, 2020 Filed Feb 20, 2020 21:06 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
SaleCommon Stock 7,453 $26.00 $193,778.00
Disclosure

SEC source: 0000898432-20-000119 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 19, 2020 Filed Feb 20, 2020 21:06 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionCommon Stock 7,453 $0.93 $6,931.29
Disclosure

SEC source: 0000898432-20-000119 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 21:04 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,136 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0000898432-20-000118 · form4.xml · derivative · entry 5

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,864

Underlying: Common Stock · 2,136 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.

F3 · derivative.expiration_date: This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 21:04 UTC SaleCommon Stock 2,136 $26.12 $55,792.32
Disclosure

SEC source: 0000898432-20-000118 · form4.xml · nonDerivative · entry 2

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,283

F1 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 21:04 UTC Exercise / conversionCommon Stock 2,136 $7.10 $15,165.60
Disclosure

SEC source: 0000898432-20-000118 · form4.xml · nonDerivative · entry 1

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 21:06 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 12,106 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000119 · form4.xml · derivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,362

Underlying: Common Stock · 12,106 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 21:06 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
SaleCommon Stock 12,106 $26.00 $314,756.00
Disclosure

SEC source: 0000898432-20-000119 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.81 to $26.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 21:06 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionCommon Stock 12,106 $0.93 $11,258.58
Disclosure

SEC source: 0000898432-20-000119 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,046

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
February 17, 2020 Filed Feb 20, 2020 21:02 UTC
Susi Roger E.Director · Chief Tech. Officer, Chairman · 10% owner
GiftCommon Stock 25,250 $0.00 $0.00
Disclosure

SEC source: 0000898432-20-000117 · form4.xml · nonDerivative · entry 1

Susi Roger E. · CIK 0001613801 · Director · Chief Tech. Officer, Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Roger E. Susi Revocable Trust

Disclosed balance after: 1,015,550

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 17:32 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 8,750 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0000898432-20-000116 · form4.xml · derivative · entry 7

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on 12/31/2013 and is fully vested and exercisable.

F4 · derivative.expiration_date: This option was granted on 12/31/2013 and is fully vested and exercisable.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 17:32 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0000898432-20-000116 · form4.xml · derivative · entry 6

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option was granted on 12/13/2013 and is fully vested and exercisable.

F3 · derivative.expiration_date: This option was granted on 12/13/2013 and is fully vested and exercisable.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 17:32 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 8,750 $0.00 Strike: $1.29 $0.00
Disclosure

SEC source: 0000898432-20-000116 · form4.xml · derivative · entry 5

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option was granted on 11/20/2012 and is fully vested and exercisable.

F2 · derivative.expiration_date: This option was granted on 11/20/2012 and is fully vested and exercisable.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 17:32 UTC Exercise / conversionCommon Stock 8,750 $1.48 $12,950.00
Disclosure

SEC source: 0000898432-20-000116 · form4.xml · nonDerivative · entry 4

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 17:32 UTC Exercise / conversionCommon Stock 17,500 $1.29 $22,575.00
Disclosure

SEC source: 0000898432-20-000116 · form4.xml · nonDerivative · entry 3

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 17:32 UTC Exercise / conversionCommon Stock 8,750 $1.29 $11,287.50
Disclosure

SEC source: 0000898432-20-000116 · form4.xml · nonDerivative · entry 2

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 17:32 UTC SaleCommon Stock 4,307 $25.48 $109,742.36
Disclosure

SEC source: 0000898432-20-000116 · form4.xml · nonDerivative · entry 1

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: This transaction was executed in multiple trades at prices ranging from $25.43 to $25.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 22:26 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000031 · form4.xml · derivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,468

Underlying: Common Stock · 5,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 22:26 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
SaleCommon Stock 5,000 $25.30 $126,500.00
Disclosure

SEC source: 0000898432-20-000031 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.30 to $25.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 22:26 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
GrantCommon Stock 5,000 $0.93 $4,650.00
Disclosure

SEC source: 0000898432-20-000031 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
January 09, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · derivative · entry 9

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
January 09, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
SaleCommon Stock 8,000 $25.23 $201,840.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · nonDerivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $25.17 to $25.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 09, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
GrantCommon Stock 8,000 $0.93 $7,440.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · nonDerivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
January 08, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · derivative · entry 8

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
January 08, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
SaleCommon Stock 8,000 $24.56 $196,480.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $24.50 to $24.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 08, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
GrantCommon Stock 8,000 $0.93 $7,440.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
January 07, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
January 07, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
SaleCommon Stock 8,000 $24.61 $196,880.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $24.55 to $24.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 07, 2020 Filed Jan 9, 2020 22:55 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
GrantCommon Stock 8,000 $0.93 $7,440.00
Disclosure

SEC source: 0000898432-20-000025 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
January 06, 2020 Filed Jan 6, 2020 23:17 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000023 · form4.xml · derivative · entry 9

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
January 06, 2020 Filed Jan 6, 2020 23:17 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
SaleCommon Stock 8,000 $24.37 $194,960.00
Disclosure

SEC source: 0000898432-20-000023 · form4.xml · nonDerivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $24.26 to $24.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 06, 2020 Filed Jan 6, 2020 23:17 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
GrantCommon Stock 8,000 $0.93 $7,440.00
Disclosure

SEC source: 0000898432-20-000023 · form4.xml · nonDerivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 1,083 $0.00 $0.00
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · derivative · entry 9

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,083

Underlying: Common Stock · 1,083 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.

F6 · derivative.expiration_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 738 $0.00 $0.00
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · derivative · entry 8

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 738

Underlying: Common Stock · 738 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.

F6 · derivative.expiration_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 15,625 $0.00 $0.00
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · derivative · entry 7

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,625

Underlying: Common Stock · 15,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.

F6 · derivative.expiration_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Tax withholdingCommon Stock 264 $25.06 $6,615.84
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 6

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,315

F3 · kind: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Exercise / conversionCommon Stock 1,083 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 5

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Vesting of restricted stock units granted to the reporting person on December 7, 2018 for which vesting and settlement were accelerated to January 6, 2020.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Tax withholdingCommon Stock 180 $25.06 $4,510.80
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 4

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,496

F3 · kind: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Exercise / conversionCommon Stock 738 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 3

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Vesting of restricted stock units granted to the reporting person on December 4, 2017 for which vesting and settlement were accelerated to January 6, 2020.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Tax withholdingCommon Stock 4,074 $25.06 $102,094.44
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 2

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,938

F3 · kind: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction.

Read SEC document
January 06, 2020 Filed Jan 8, 2020 21:58 UTC
McCreery John KChief Operating Officer
Exercise / conversionCommon Stock 15,625 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 1

McCreery John K · CIK 0001703458 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 03, 2020 Filed Jan 6, 2020 23:17 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000023 · form4.xml · derivative · entry 8

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,468

Underlying: Common Stock · 14,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
January 03, 2020 Filed Jan 6, 2020 23:17 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
SaleCommon Stock 14,000 $23.82 $333,480.00
Disclosure

SEC source: 0000898432-20-000023 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $23.50 to $24.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 03, 2020 Filed Jan 6, 2020 23:17 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
GrantCommon Stock 14,000 $0.93 $13,020.00
Disclosure

SEC source: 0000898432-20-000023 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 23:17 UTC
JOHNSON BRENTExec. VP. of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-20-000023 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,468

Underlying: Common Stock · 6,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.